Abstract
Recently, the spiropiperidyl derivate RS 86, a specific muscarinic agonist, attracted attention in the context of the cholinergic hypothesis of Alzheimer's disease. This compound revived the interest in the clinical usefulness of cholinergic agents in mania. In the present report, the findings in eight patients subjected to the same design will be summarized
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
